Literature DB >> 33557987

Elevated secondary infection rates in patients with coronavirus disease 2019 (COVID-19) requiring extracorporeal membrane oxygenation.

Joseph E Marcus1, Valerie G Sams2, Alice E Barsoumian1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33557987      PMCID： PMC7925975          DOI： 10.1017/ice.2021.61

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


× No keyword cloud information.
  4 in total

1.  Beyond the Pandemic: The Value of Antimicrobial Stewardship.

Authors:  Souha S Kanj; Paula Ramirez; Camilla Rodrigues
Journal:  Front Public Health       Date:  2022-06-27

2.  COVID-19, ECMO, and respiratory infection: A new triad?

Authors:  Sara Zaidi; Dang Nguyen; Amer Harky
Journal:  J Card Surg       Date:  2022-09-08       Impact factor: 1.778

3.  A fibrin enhanced thrombosis model for medical devices operating at low shear regimes or large surface areas.

Authors:  Rodrigo Méndez Rojano; Angela Lai; Mansur Zhussupbekov; Greg W Burgreen; Keith Cook; James F Antaki
Journal:  PLoS Comput Biol       Date:  2022-10-03       Impact factor: 4.779

4.  Multiple Secondary Healthcare-Associated Infections Due to Carbapenem-Resistant Organisms in a Critically Ill COVID-19 Patient on Extensively Prolonged Venovenous Extracorporeal Membrane Oxygenation Support-A Case Report.

Authors:  Hiroaki Baba; Hajime Kanamori; Issei Seike; Ikumi Niitsuma-Sugaya; Kentaro Takei; Kengo Oshima; Yudai Iwasaki; Yuko Ogata; Hirona Nishimaki; Daisuke Konno; Takuya Shiga; Koji Saito; Koichi Tokuda; Tetsuji Aoyagi
Journal:  Microorganisms       Date:  2021-12-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.